Internal Medicine, Nephrology · Hinsdale, IL
NPI
1639259740
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
911 N Elm St, Suite 102
Hinsdale, IL, 60521
Phone (630) 495-9356
Groups this clinician bills Medicare through
Medicare paid, 2024
$221K
2,049 services
Medicare patients, 2024
609
Average age 77
Drug cost, 2024
$1.4M
1,438 prescriptions
Company payments, 2025
$35K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anis A Rauf was code 99233 (hospital e&m - subsequent), 546 times for 210 patients. In total Anis A Rauf billed 2,049 services in 30 codes, and Medicare paid $221K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 546 | 210 | $94.93 | $52K |
| 99232 Hospital E&M - Subsequent | Facility | 328 | 157 | $63.35 | $21K |
| 99214 Office E&M - Established | Office | 232 | 159 | $71.08 | $16K |
| 99223 Hospital E&M - Initial | Facility | 230 | 189 | $138.59 | $32K |
| 90966 ESRD Related Services (not dialysis) | Office | 184 | 48 | $226.85 | $42K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 168 | 30 | $50.13 | $8,421 |
| 90960 ESRD Related Services (not dialysis) | Office | 111 | 19 | $280.15 | $31K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 96 | 89 | $13.03 | $1,251 |
| 99213 Office E&M - Established | Office | 30 | 28 | $44.34 | $1,330 |
| 99204 Office E&M - New | Office | 25 | 25 | $118.60 | $2,965 |
| 99222 Hospital E&M - Initial | Facility | 16 | 12 | $101.06 | $1,617 |
| 99291 Critical Care E&M | Facility | 15 | 12 | $173.23 | $2,598 |
By year: 2022 $277K for 2,610 services; 2023 $249K for 2,397 services; 2024 $221K for 2,049 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anis A Rauf prescribed most often to Medicare patients was Furosemide, with 146 prescriptions and refills. In total Anis A Rauf wrote 1,438 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 146 | 287 | 38 | $957 |
| Losartan Potassium Generic | 105 | 299 | 36 | $1,593 |
| Torsemide Generic | 101 | 241 | 33 | $3,451 |
| Allopurinol Generic | 75 | 211 | 23 | $1,048 |
| Sevelamer Carbonate Generic | 61 | 108 | 23 | $8,401 |
| Potassium Chloride Generic | 60 | 118 | 13 | $2,157 |
| Nifedipine Er Nifedipine | 56 | 156 | 17 | $3,825 |
| Farxiga Dapagliflozin Propanediol | 50 | 104 | 13 | $57K |
| Amlodipine Besylate Generic | 49 | 126 | 18 | $400 |
| Lokelma Sodium Zirconium Cyclosilicate | 49 | 61 | 13 | $43K |
| Lisinopril Generic | 43 | 108 | 15 | $196 |
| Spironolactone Generic | 38 | 91 | Under 11 | $479 |
| Rayaldee Calcifediol | 37 | 53 | Under 11 | $64K |
| Tamsulosin Hcl Generic | 31 | 83 | Under 11 | $434 |
| Atorvastatin Calcium Generic | 21 | 53 | Under 11 | $195 |
Brand drugs: 288 claims; generic drugs: 1,150 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anis A Rauf $35K ($35K in general payments such as food, travel and fees) from 20 companies. The largest payer was GlaxoSmithKline, LLC. with $18K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 22 | $18K |
| ANI Pharmaceuticals, Inc. ANIP | 22 | $12K |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $2,882 |
| Cipla USA Inc. CIPLA.NS | 1 | $400 |
| Amgen Inc. AMGN | 15 | $290 |
| Travere Therapeutics, Inc. TVTX | 4 | $269 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $233 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $221 |
| OPKO Pharmaceuticals, LLC | 6 | $137 |
| Akebia Therapeutics Inc AKBA | 3 | $96.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.